Total Payments
$41,913
2024 Payments
$625.00
Companies
6
Transactions
95
Payment Breakdown by Category
Education$19,205 (45.8%)
Other$18,382 (43.9%)
Consulting$2,938 (7.0%)
Research$1,109 (2.6%)
Food & Beverage$278.88 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $19,205 | 55 | 45.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,382 | 33 | 43.9% |
| Consulting Fee | $2,938 | 2 | 7.0% |
| Unspecified | $1,109 | 2 | 2.6% |
| Food and Beverage | $278.88 | 3 | 0.7% |
Payments by Type
General
$40,803
93 transactions
Research
$1,109
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | $26,975 | 58 | $0 (2024) |
| AveXis | $8,537 | 30 | $0 (2019) |
| PTC Therapeutics, Inc. | $3,168 | 4 | $0 (2022) |
| PFIZER INC. | $2,700 | 1 | $0 (2023) |
| F. Hoffmann-La Roche AG | $484.34 | 1 | $0 (2021) |
| Sarepta Therapeutics, Inc. | $48.64 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $625.00 | 1 | Novartis Gene Therapies, Inc. (fka Avexis, Inc.) ($625.00) |
| 2023 | $7,366 | 15 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ($4,666) |
| 2022 | $12,718 | 20 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ($11,482) |
| 2021 | $2,986 | 4 | PTC Therapeutics, Inc. ($1,750) |
| 2020 | $9,553 | 24 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ($9,450) |
| 2019 | $8,665 | 31 | AveXis ($8,537) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/16/2024 | Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | ZOLGENSMA (Drug) | — | Cash or cash equivalent | $625.00 | Research |
| Study: Research Medical Writing and Publication Support • Category: Neurology | ||||||
| 12/20/2023 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| 10/27/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $333.33 | General |
| Category: GENE THERAPY | ||||||
| 06/29/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $128.57 | General |
| Category: GENE THERAPY | ||||||
| 06/29/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $81.82 | General |
| Category: GENE THERAPY | ||||||
| 06/20/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $428.57 | General |
| Category: GENE THERAPY | ||||||
| 06/20/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $81.82 | General |
| Category: GENE THERAPY | ||||||
| 06/14/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $108.36 | General |
| Category: GENE THERAPY | ||||||
| 04/25/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $81.82 | General |
| Category: GENE THERAPY | ||||||
| 04/25/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $80.00 | General |
| Category: GENE THERAPY | ||||||
| 03/19/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $128.57 | General |
| Category: GENE THERAPY | ||||||
| 03/13/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $2,909.09 | General |
| Category: GENE THERAPY | ||||||
| 03/09/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $81.82 | General |
| Category: GENE THERAPY | ||||||
| 03/03/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $105.20 | General |
| Category: GENE THERAPY | ||||||
| 03/01/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $71.43 | General |
| Category: GENE THERAPY | ||||||
| 03/01/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $45.45 | General |
| Category: GENE THERAPY | ||||||
| 12/12/2022 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $71.43 | General |
| Category: GENE THERAPY | ||||||
| 12/09/2022 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $45.45 | General |
| Category: GENE THERAPY | ||||||
| 12/01/2022 | Sarepta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $48.64 | General |
| 11/28/2022 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $515.00 | General |
| Category: GENE THERAPY | ||||||
| 11/01/2022 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $45.45 | General |
| Category: GENE THERAPY | ||||||
| 10/31/2022 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $285.71 | General |
| Category: GENE THERAPY | ||||||
| 10/21/2022 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $350.00 | General |
| Category: GENE THERAPY | ||||||
| 10/21/2022 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $50.00 | General |
| Category: GENE THERAPY | ||||||
| 10/12/2022 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $350.00 | General |
| Category: GENE THERAPY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Research Medical Writing and Publication Support | Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | $625.00 | 1 |
| SYSTEMIC GENE DELIVERY CLINICAL TRIAL FOR DUCHENNE MUSCULAR DYSTROPHY DMD | F. Hoffmann-La Roche AG | $484.34 | 1 |
About Dr. Richard Shell, MD
Dr. Richard Shell, MD is a Pediatric Pulmonology healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1497741110.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Shell, MD has received a total of $41,913 in payments from pharmaceutical and medical device companies, with $625.00 received in 2024. These payments were reported across 95 transactions from 6 companies. The most common payment nature is "Education" ($19,205).
Ad
Practice Information
- Specialty Pediatric Pulmonology
- Location Columbus, OH
- Active Since 09/27/2005
- Last Updated 12/17/2025
- Taxonomy Code 2080P0214X
- Entity Type Individual
- NPI Number 1497741110
Products in Payments
- ZOLGENSMA (Biological) $34,887
- ZOLGENSMA (Drug) $625.00
- EMFLAZA (Drug) $230.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Pulmonology Doctors in Columbus
Swaroop Pinto, Md, MD
Pediatric Pulmonology — Payments: $246.45
Pediatric Pulmonology $246.45
Stephen Kirkby, M.d, M.D
Pediatric Pulmonology — Payments: $142.29
Pediatric Pulmonology $142.29
Dr. Eric Mull, D.o, D.O
Pediatric Pulmonology — Payments: $16.33
Pediatric Pulmonology $16.33
Sarah Cohen, Md, MD
Pediatric Pulmonology — Payments: $14.77
Pediatric Pulmonology $14.77
Dr. Debra Boyer, Md, MD
Pediatric Pulmonology — Payments: $10.63
Pediatric Pulmonology $10.63
Dr. Kyndall Smith, Md, MD
Pediatric Pulmonology — Payments: $7.76
Pediatric Pulmonology $7.76